NLS Research

Gubra have announced the launch of a new research collaboration agreement with Sanofi focusing on the discovery of gut peptides. The new research program initiated between Gubra and Sanofi builds upon the  established research consortium between Gubra, Gentofte Hospital and the University of Copenhagen partly funded by the Danish National Advanced Technology foundation. “We are […]

Teva Pharmaceutical is starting a global research collaboration to examine multiple pathways of neuroprotection in Huntington’s disease. Teva Pharmaceutical Industries Ltd. recently announced the formation of a research collaboration to “create a comprehensive understanding and drive insights into neuroprotective therapeutic approaches” in Huntington’s disease, a neurodegenerative genetic disorder that affects muscle coordination and leads to […]

Researchers at Karolinska Institutet have developed the first method for directly measuring the extent to which drugs reach their targets in the cell. As described in the scientific journal Science, the method could make a significant contribution to the development of new, improved drug substances. Previously, no method has been available for directly measuring the […]

AstraZeneca is funding ten research projects at the Science for Life Laboratory. The projects will begin during the fall of 2013 and are intended to improve the understanding of the molecular mechanisms surrounding tumor disease, heart failure, diabetes, inflammatory diseases, asthma and COPD, CNS diseases and stem cell biology. The various projects will be led […]

Chromosomal changes after age 50 appear to indicate risk of blood cancer. The discovery started with GWAS—genome-wide association studies—that find genetic variations that might be responsible for a trait or a disease. When researchers conduct GWAS, they use data on sequence variations in the genomes of thousands of individuals to find variants that are associated […]

With construction starting in April 2013 the first tenants are expected to move in to the new Oslo Cancer Cluster Innovation Park in May 2015. The aim of Oslo Cancer Cluster Innovation Park AS is to reduce the development time for new medicines and diagnostics for cancer. Park will become the first to combine clinical […]